SOURCE: Information Forecast, Inc.

Information Forecast, Inc.

July 05, 2011 07:39 ET

Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference

Attain Vital Information to Facilitate Growth in the Nation's Biodefense Medical Countermeasures Pipeline

WASHINGTON, DC--(Marketwire - Jul 5, 2011) - Infocast brings its highly acclaimed 9th Annual Biodefense Vaccines & Therapeutics conference to the Almas Temple Club in Washington D.C. from July 20-22, 2011. This conference will detail and explain the Department of Health and Human Services' new strategy for improving the nation's biodefense medical countermeasures pipeline. This meeting is essential for the biotechnology & pharmaceutical sector, research institutions and universities to come together and discuss how new government initiatives and incentives will drive greater opportunities for partnership and collaboration.

This year's Conference features two insightful pre-conference symposia. First, the "Animal Models and Regulatory Science" symposium will highlight the Food and Drug Administration's (FDA) regulatory science initiatives and efforts, and feature case studies of ongoing animal efficacy studies for medical countermeasures. Second, the "Developments in Biodefense Technology Platforms" symposium will provide the latest in technology platform projects intended to impact multiple medical countermeasures products, and improve the capabilities to meet bioterrorist and emerging infectious disease threats.

Biodefense Vaccines & Therapeutics conference is the ideal venue for participants seeking a role in the national biodefense effort to interact face-to-face with government representatives, get the most up-to-date information on government's programs & funding priorities and provide instant feedback. Attendees will also get a rare opportunity to help shape the government's strategy for expanding the biodefense medical countermeasure sector.

The conference will provide the latest information on the federal government's chemical, biological, radiological and nuclear (CBRN) changes and its potential impact on the biodefense industry. It features speakers from government agencies including the Department of Health and Human Services (HHS), Food and Drug Administration (FDA), National Institute of Allergy and Infectious Disease (NIAID), Department of Defense (DOD) and many others.

For more information, to REGISTER for the Summit, or to join us as a Sponsor, please visit the event website at www.infocastinc.com/biodef11 or contact Infocast at 818-888-4444.

About Infocast

Infocast is an event production company with twenty-five years of successful industry experience. The Biodefense Vaccines & Therapeutics conference series has brought together senior government representatives, key biotechnology and pharmaceutical companies, research contractors, institutes and universities, and the public health community to address the need for biodefense medical countermeasures.

Contact Information

  • Contact:
    Amy Tam
    818-888-4444